共 225 条
[1]
Kekelidze M(2013)Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation World J Gastroenterol 19 8502-14
[2]
D’Errico L(2005)Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer Clin Ther 27 684-94
[3]
Pansini M(2013)Association of the epithelial-to-mesenchymal transition phenotype with responsiveness to the p21-activated kinase inhibitor, PF-3758309, in colon cancer models Front Pharm 4 35-712
[4]
Tyndall A(2016)CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype Oncotarget 7 78698-51
[5]
Hohmann J(2019)Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer Theranostics 9 2235-64
[6]
Wong SF(2017)Rationally co-targeting divergent pathways in KRAS wild-type colorectal cancers by CANscript technology reveals tumor dependence on Notch and Erbb2 Sci Rep 7 357-82
[7]
Pitts TM(2015)Significant association of oncogene YAP1 with poor prognosis and cetuximab resistance in colorectal cancer patients Clin Cancer Res 21 2171-12
[8]
Kulikowski GN(2018)Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells Oncol Rep 40 1601-10
[9]
Tan AC(2021)ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation Nat Commun 12 1-25
[10]
Murray BW(2021)Effects of YAP1 and SFRP2 overexpression on the biological behavior of colorectal cancer cells and their molecular mechanisms J Gastrointest Oncol 12 414-75